¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Çѱ¹°£´ãÃé¿Ü°úÇÐȸ Á¦13Â÷ ±¹Á¦½Ì±ÛÅäÇȽÉÆ÷Áö¿ò : 2018-09-14

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Çѱ¹°£´ãÃé¿Ü°úÇÐȸ Á¦13Â÷ ±¹Á¦½Ì±ÛÅäÇȽÉÆ÷Áö¿ò : 2018-09-14
±³À°ÀÏÀÚ : 2018-09-14
±³À°Àå¼Ò : ¿©¼ö ¿¥ºíÈ£ÅÚ 1Ãþ ±×·£µåº¼·ë  
±³À°ÁÖÁ¦ : Á¦13Â÷ ±¹Á¦½Ì±ÛÅäÇȽÉÆ÷Áö¿ò      
ÁÖÃÖ±â°ü : Çѱ¹°£´ãÃé¿Ü°úÇÐȸ
´ã´çÀÚ : À̺¸¹Ì
¿¬¶ôó : 02-2227-8299  
À̸ÞÀÏ : khbps@khbp.or.kr      
±³À°Á¾·ù : ¿Ü°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : Àü¶ó³²µµ
±³À°½Ã°£ : 4 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í [Æò»ýȸ¿ø,Á¤È¸¿ø] »çÀüµî·Ï: 50,000¿ø / ÇöÀåµî·Ï 70,000¿ø [Àü°øÀÇ, °£È£»ç, ±ºÀÇ°ü] »çÀüµî·Ï: 30,000¿ø / ÇöÀåµî·Ï 50,000¿ø [ºñȸ¿ø] »çÀüµî·Ï: 70,000¿ø / ÇöÀåµî·Ï: 100,000¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 12:40~12:50 Introduction: Posthepatectomy Liver Failure (PHLF)  ¹Ú»óÀç(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 12:50~13:10 Various factors associated with liver regeneration after hepatectomy  ±è¼¼ÁØ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 13:10~13:30 Quantified risk assessment of PHLF in cirrhotic liver  Á¤µ¿È¯(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 13:30~13:50 Impact and prediction of chemotherapy-associated liver injury  ÇÑ´ëÈÆ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 13:50~14:10 Risk prediction of PHLF in patients with perihilar cholangiocarcinoma  ÃÖ»õº°(°í·ÁÀÇ´ë) 
Åä·Ð 09¿ù 14ÀÏ ±×·£µåº¼·ë 14:10~14:20 Discussion  () 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 14:20~14:50 Virtual and augmented reality for image-guided surgery  Maki Sugimoto(International University of Health and Welfare) 
È޽Ġ09¿ù 14ÀÏ ±×·£µåº¼·ë 14:50~15:10 Coffee Break  () 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 15:10~15:30 Knack and pitfall of various PVE techniques  °í±â¿µ(¿ï»êÀÇ´ë ¿µ»óÀÇÇаú) 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 15:30~15:50 Outcome and safety of PVE between cirrhotic, cholestatic, and normal liver  ¾È±Ù¼ö(°è¸íÀÇ´ë) 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 15:50~16:05 What next when PVE fails to induce enough hypertrophy?  ÀÓâ¼·(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 16:05~16:20 Drawback of PVE: oncologic perspectives  ÃÖ¿µ·Ï(ºÐ´ç¼­¿ï´ë) 
Åä·Ð 09¿ù 14ÀÏ ±×·£µåº¼·ë 16:20~16:30 Discussion  () 
È޽Ġ09¿ù 14ÀÏ ±×·£µåº¼·ë 16:30~16:40 Break  () 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 16:40~16:55 Indication of PBD with regard to background liver, FLR and patient¡¯s condition  ±èÈñÁØ(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 16:55~17:10 Optimal preoperative bilirubin level with regard to background liver, FLR and patient¡¯s condition  ¼­ÇüÀÏ(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 17:10~17:25 Endoscopic biliary drainage: is it oncologically safe?  ±è¿ëÈÆ(°è¸íÀÇ´ë) 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 17:25~17:40 Simultaneous PVE and PBD; is it feasible?  È«ÅÂÈ£(°¡Å縯ÀÇ´ë) 
Åä·Ð 09¿ù 14ÀÏ ±×·£µåº¼·ë 17:40~17:50 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Çѱ¹°£´ãÃé¿Ü°úÇÐȸ Á¦13Â÷ ±¹Á¦½Ì±ÛÅäÇȽÉÆ÷Áö¿ò : 2018-09-14""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ±¹¸³¾Ï¼¾ÅÍ ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ǹ®´õ½Ê°úÁ¤ : 2018-09-15
´ÙÀ½±Û ºÎ»ê¼Ò¾Æ°úÇÐȸ Á¤±â Çмú Áý´äȸ : 2018-09-13
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20619 °æ³² »ï¼ºÃ¢¿øº´¿ø (¿Â¶óÀÎ)»ï¼ºÃ¢¿ø Ambulatory Pediatrics 2024 : 2024-06-29 0 130 2024-04-30
20618 °æºÏ Á¦8Â÷ ´ëÇѸðüžÆÀÇÇÐȸ °³¿øÀǸ¦ À§ÇÑ ¿¬¼ö°­ÁÂ(¿µ³²) : 2024-06-29 0 51 2024-04-30
20617 ¼­¿ï °Ç±¹´ëÇб³º´¿ø 2024 KUMC Precision Medicine Lung Cancer Conference : 2024-06-28 0 44 2024-04-30
20616 ¼­¿ï 2024 ´ëÇÑÇ÷¾×ÇÐȸ ÀûÇ÷±¸Áúȯ¿¬±¸ ½ÉÆ÷Áö¾ö : 2024-06-28 0 60 2024-04-30
20615 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-°³¿ø°¡¿¡¼­ ÀÇ·ÚÇÑ µÎ°æºÎ¾Ï ȯÀÚÀÇ Ä¡·á ¹× °æ°ú : 2024-06-27 0 50 2024-04-30
20614 ¼­¿ï 2024³â ´ëÇÑÈäºÎ¿µ»óÀÇÇÐȸ ¿¬¼ö°­Á : 2024-06-23 0 46 2024-04-30
20613 ´ë±¸ ´ëÇѽºÆ÷Ã÷ÀÇÇÐȸ Sports Medicine Symposium 2024 in Daegu : 2024-06-23 0 73 2024-04-29
20612 ¼­¿ï 2024³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦12Â÷ Clinical Densitometry Course : 2024-06-23 0 67 2024-04-29
20611 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 1Â÷(2ÀÏÂ÷) : 2024-06-22 0 63 2024-04-29
20610 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø (¿Â¶óÀÎ) 6¿ù 21ÀÏ ±Ý¿äÁý´ãȸ(ÀÌ°ü ÁúȯÀÇ Áø´Ü°ú Ä¡·á) : 2024-06-21 0 63 2024-04-29
20609 °æ±â ¾È»ê ¹× ½ÃÈ­Áö¿ª À̺ñÀÎÈÄ°ú Àǻ縦 À§ÇÑ Áý´ãȸ(¾È¸é¸¶ºñ) : 2024-06-21 0 43 2024-04-29
20608 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 1Â÷(1ÀÏÂ÷) : 2024-06-21 0 58 2024-04-29
20607 ¼­¿ï 2024 ´ëÇÑȯ°æõ½ÄÆóÁúȯÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-21 0 59 2024-04-29
20606 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-¿Ü·¡¿¡¼­ °£´ÜÇÏ°Ô ÇÒ ¼ö ÀÖ´Â À½¼ºÄ¡·á : 2024-06-20 0 53 2024-04-29
20605 ´ë±¸ ´ëÇÑ»êºÎÀΰúÇÐȸ ´ë±¸Áöȸ ¿¬¼ö°­Á : 2024-06-20 0 47 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷